Earnings Call · Q3 FY2021·2021-11-12

Q3 21EPS +25.00%·Rev n/aQ2 21EPS +33.33%·Rev n/aQ1 21EPS +16.67%·Rev n/aQ4 20EPS n/a·Rev n/a⚠ consensus missing

Iterum Therapeutics plc ITRMF

Louise Barrett — Senior Vice President for Legal Affairs

Corey Fishman — Chief Executive Officer

Judy Matthews — Chief Financial Officer

−6.7%1d on move date−7.5% vs SPY3d−10.8%5d−17.4%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ITRMF calls or request research access.

More ITRMF calls Browse calls Request research access